- Januvia the oral drug by Merck's for the treatment of type 2 diabetes by junavia
Januvia is Merck's investigational oral (DDP-4) dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. Junavia is the first in a new class of oral medications that enhance the body’s own ability to lower blood sugar (glucose) when it is elevated. DPP-4 inhibitors work by enhancing a natural body system that lessens blood sugar, the incretin system.
in Public bookmarks with buy_januvia diabetes_buy diabetes_januvia
Note: Januvia is Merck's investigational oral (DDP-4) dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. Junavia is the first in a new class of oral medications that enhance the body’s own ability to lower blood sugar (glucose) when it is elevated. DPP-4 inhibitors work by enhancing a ...morenatural body system that lessens blood sugar, the incretin system.
diabetes_januvia from all users